NCT03814395 (PKUBC-T) is a clinical trial of No intervention in Health Problems in Pregnancy, sponsored by Peking University.

Who is sponsoring NCT03814395?

NCT03814395 is sponsored by Peking University.

What drugs are being tested in NCT03814395?

Interventions in NCT03814395: No intervention.

What condition does NCT03814395 study?

NCT03814395 studies Health Problems in Pregnancy, Pregnancy Outcomes, Gestational Diabetes, Gestational Hypertension, Preterm Birth, Obesity, Mother-Infant Interaction, Child Development, Anemia.

Is NCT03814395 still recruiting?

NCT03814395 is currently status unknown. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT03814395: PKUBC-T

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peking University Birth Cohort in Tongzhou

Status unknown Last updated 18 November 2023

What this trial tests

trial testing No intervention in Health Problems in Pregnancy in 5,426 participants. Status unknown.

Timeline

28 June 2018

Primary endpoint
27 August 2019

28 August 2025

Quick facts

Lead sponsor	Peking University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	5,426
Start date	28 June 2018
Primary completion	27 August 2019
Estimated completion	28 August 2025
Sites	1 location across China

Drugs / interventions tested

No intervention

Conditions studied

Health Problems in Pregnancy — all drugs for Health Problems in Pregnancy →
Pregnancy Outcomes — all drugs for Pregnancy Outcomes →
Gestational Diabetes — all drugs for Gestational Diabetes →
Gestational Hypertension — all drugs for Gestational Hypertension →

Sponsor

Peking University

Who can join

Adults 18 to 49, female only, with Health Problems in Pregnancy or Pregnancy Outcomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The PKUBC-T is a prospective cohort study carried out in Tongzhou district of Beijing, China. The primary aim of this study is to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and child health. Data are collected regarding environmental, nutritional and lifestyle exposures as well as short-term and long-term health outcomes of mothers and their children from birth to 6 years old. Biological samples including blood and tissue samples are also collected from mothers and their children.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of dynamic change in fetuin-A levels from the first to the second trimester on insulin resistance and gestational diabetes mellitus: a nested case-control study.
Jin C, Lin L, Han N, Zhao Z, et al · · 2020 · cited 17× · PMID 31958310 · DOI 10.1136/bmjdrc-2019-000802
Medication Usage Record-Based Predictive Modeling of Neurodevelopmental Abnormality in Infants under One Year: A Prospective Birth Cohort Study.
Zhou T, Shen Y, Lyu J, Yang L, et al · · 2024 · cited 3× · PMID 38610136 · DOI 10.3390/healthcare12070713
Interpretable machine learning to identify important predictors of birth weight: A prospective cohort study.
Liu Z, Han N, Su T, Ji Y, et al · · 2022 · cited 3× · PMID 36440327 · DOI 10.3389/fped.2022.899954

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other Peking University trials

Trials by the same sponsor.

NCT07519122 — Fangshan Active Nutrition Initiative · NA · not yet recruiting
NCT07466238 — HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer · NA · recruiting
NCT07480525 — Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder · NA · not yet recruiting
NCT07454031 — Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma · Phase 1 · not yet recruiting
NCT07466225 — HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03814395 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03814395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing